BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological activity of novel oxazolidinones. 2009

Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Department of Medicinal Chemistry, New Drug Discovery Research, Ranbaxy Research Laboratories, Plot-20, Sector-18, Udyog Vihar, Gurgaon 122001, India. biswajit.das@ranbaxy.com

A number of 5-substituted derivatives of Ranbezolid, a novel oxazolidinone were synthesized. Antibacterial activity of the compounds against a number of sensitive and resistant bacteria showed promising results.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D010080 Oxazoles Five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position, in distinction from ISOXAZOLES where they are at the 1,2 positions. Oxazole,1,3-Oxazolium-5-Oxides,Munchnones,1,3 Oxazolium 5 Oxides
D005663 Furans Compounds with a 5-membered ring of four carbons and an oxygen. They are aromatic heterocycles. The reduced form is tetrahydrofuran. Tetrahydrofurans
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D001419 Bacteria One of the three domains of life (the others being Eukarya and ARCHAEA), also called Eubacteria. They are unicellular prokaryotic microorganisms which generally possess rigid cell walls, multiply by cell division, and exhibit three principal forms: round or coccal, rodlike or bacillary, and spiral or spirochetal. Bacteria can be classified by their response to OXYGEN: aerobic, anaerobic, or facultatively anaerobic; by the mode by which they obtain their energy: chemotrophy (via chemical reaction) or PHOTOTROPHY (via light reaction); for chemotrophs by their source of chemical energy: CHEMOLITHOTROPHY (from inorganic compounds) or chemoorganotrophy (from organic compounds); and by their source for CARBON; NITROGEN; etc.; HETEROTROPHY (from organic sources) or AUTOTROPHY (from CARBON DIOXIDE). They can also be classified by whether or not they stain (based on the structure of their CELL WALLS) with CRYSTAL VIOLET dye: gram-negative or gram-positive. Eubacteria
D015195 Drug Design The molecular designing of drugs for specific purposes (such as DNA-binding, enzyme inhibition, anti-cancer efficacy, etc.) based on knowledge of molecular properties such as activity of functional groups, molecular geometry, and electronic structure, and also on information cataloged on analogous molecules. Drug design is generally computer-assisted molecular modeling and does not include PHARMACOKINETICS, dosage analysis, or drug administration analysis. Computer-Aided Drug Design,Computerized Drug Design,Drug Modeling,Pharmaceutical Design,Computer Aided Drug Design,Computer-Aided Drug Designs,Computerized Drug Designs,Design, Pharmaceutical,Drug Design, Computer-Aided,Drug Design, Computerized,Drug Designs,Drug Modelings,Pharmaceutical Designs
D020713 Vancomycin Resistance Nonsusceptibility of bacteria to the action of VANCOMYCIN, an inhibitor of cell wall synthesis.
D023303 Oxazolidinones Derivatives of oxazolidin-2-one. They represent an important class of synthetic antibiotic agents. 1,3-Oxazolidin-2-one,Oxazolidin-2-one,Oxazolidinone,1,3-Oxazolidine-2-one,2-Oxazolidone,2-oxazolidinone,1,3 Oxazolidin 2 one,1,3 Oxazolidine 2 one,2 Oxazolidone,2 oxazolidinone,Oxazolidin 2 one

Related Publications

Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Synthesis and biological evaluation of novel benzoxazinyl-oxazolidinones as potential antibacterial agents.
July 2013, Bioorganic & medicinal chemistry letters,
Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Synthesis and in vitro antibacterial activity of novel methylamino piperidinyl oxazolidinones.
September 2007, Bioorganic & medicinal chemistry letters,
Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Synthesis and antibacterial activity of novel oxazolidinones bearing N-hydroxyacetamidine substituent.
May 2006, Bioorganic & medicinal chemistry letters,
Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Effects of positional and geometrical isomerism on the biological activity of some novel oxazolidinones.
January 2005, Bioorganic & medicinal chemistry letters,
Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Synthesis and in vitro antibacterial activity of novel 3-azabicyclo[3.3.0]octanyl oxazolidinones.
September 2012, Chemical biology & drug design,
Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Synthesis and antibacterial activity of pyrroloaryl-substituted oxazolidinones.
December 2003, Bioorganic & medicinal chemistry letters,
Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Synthesis and antibacterial activity of 5-substituted oxazolidinones.
January 2003, Bioorganic & medicinal chemistry,
Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Synthesis and antibacterial activity of substituted oxotriazolylphenyl oxazolidinones.
July 2007, Chemical biology & drug design,
Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Synthesis and SAR of novel oxazolidinones: discovery of ranbezolid.
October 2005, Bioorganic & medicinal chemistry letters,
Biswajit Das, and A V S Rajarao, and Sonali Rudra, and Ajay Yadav, and Abhijit Ray, and Manisha Pandya, and Ashok Rattan, and Anita Mehta
Anti-tubercular agents. Part 6: synthesis and antimycobacterial activity of novel arylsulfonamido conjugated oxazolidinones.
March 2011, European journal of medicinal chemistry,
Copied contents to your clipboard!